ASCO 2019 | Enfortumab vedotin for bladder cancer

Name: Enfortumab vedotin for bladder cancer
Uploaded: 2019-06-02T23:28:07Z
Duration: 2 min 9 s
Description: Bradley McGregor, MD, of the Dana-Farber Cancer Institute, Boston, MA discusses enfortumab vedotin for treating bladder cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Bradley McGregor • 2 Jun 2019

ASCO 2019

Bladder Cancer Genitourinary Cancer Antibodies Enfortumab vedotin

Bradley McGregor, MD, of the Dana-Farber Cancer Institute, Boston, MA discusses enfortumab vedotin for treating bladder cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.